Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 9 Similar Profiles
Neoplasms
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Pharmacokinetics
Medicine & Life Sciences
Rhabdomyosarcoma
Medicine & Life Sciences
temozolomide
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2002 2024
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
Neoplasms
Mechanisms of Resistance to Immunotherapy in Osteosarcoma
Modiano, J., Farrar, M. A., Subramanian, S., Vallera, D. A. & Weigel, B. J.
9/1/18 → 8/31/20
Project: Research project
osteosarcoma
immunotherapy
resistance mechanisms
irinotecan
Ifosfamide
Vincristine
Doxorubicin
Pediatrics
Phase I and II Pediatric Oncology Clinical Research Prog
Weigel, B. J. & Greengard, E. G.
7/1/15 → 6/30/20
Project: Research project
Medical Oncology
Pediatrics
Research
Research Output 1998 2019
Identification of aggressive Gardner syndrome phenotype associated with a de novo APC variant, c.4666dup
Kiessling, P., Dowling, E., Huang, Y., Ho, M. L., Balakrishnan, K., Weigel, B. J., Highsmith, W. E., Niu, Z. & Schimmenti, L. A., Apr 1 2019, In : Cold Spring Harbor molecular case studies. 5, 2Research output: Contribution to journal › Article
Open Access
Gardner Syndrome
Phenotype
Tooth Abnormalities
APC Genes
Osteoma
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group
Malempati, S., Weigel, B. J., Chi, Y. Y., Tian, J., Anderson, J. R., Parham, D. M., Teot, L. A., Rodeberg, D. A., Yock, T. I., Shulkin, B. L., Spunt, S. L., Meyer, W. H. & Hawkins, D. S., Jan 15 2019, In : Cancer. 125, 2, p. 290-297 8 p.Research output: Contribution to journal › Article
temozolomide
Rhabdomyosarcoma
Drug Therapy
irinotecan
Vincristine
2
Citations
(Scopus)
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Chuk, M. K., Widemann, B. C., Minard, C. G., Liu, X., Kim, A. R., Bernhardt, M. B., Kudgus, R. A., Reid, J. M., Voss, S. D., Blaney, S., Fox, E. & Weigel, B. J., Aug 1 2018, In : Pediatric Blood and Cancer. 65, 8, e27077.Research output: Contribution to journal › Article
Open Access
Neoplasms
Maximum Tolerated Dose
Pharmacokinetics
Proteinuria
Fatigue
4
Citations
(Scopus)
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
Schafer, E. S., Rau, R. E., Berg, S., Liu, X., Minard, C. G., D'Adamo, D., Scott, R., Reyderman, L., Martinez, G., Devarajan, S., Reid, J. M., Fox, E., Weigel, B. J. & Blaney, S. M., Aug 1 2018, In : Pediatric Blood and Cancer. 65, 8, e27066.Research output: Contribution to journal › Article
eribulin
Microtubules
Pharmacokinetics
Neutropenia
Neoplasms
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)
Geller, J. I., Fox, E., Turpin, B. K., Goldstein, S. L., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Berg, S. L. & Weigel, B. J., Dec 1 2018, In : Cancer. 124, 23, p. 4548-4555 8 p.Research output: Contribution to journal › Article
Open Access
Vascular Endothelial Growth Factor Receptor
Protein-Tyrosine Kinases
Neoplasms
Pharmacokinetics
Hypertension